ArticleMolecular cancer therapeutics2017

Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.

Bingbing Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.